Milae Bioresources Co., Ltd. (KOSDAQ:218150)
South Korea · Delayed Price · Currency is KRW 3,145.00
+105.00 (3.45%)
At close: Apr 3, 2026
Milae Bioresources Revenue
In the year 2025, Milae Bioresources had annual revenue of 67.55B KRW with 8.17% growth. Milae Bioresources had revenue of 17.39B in the quarter ending December 31, 2025, with 25.17% growth.
Revenue
67.55B
Revenue Growth
+8.17%
P/S Ratio
0.91
Revenue / Employee
1.44B
Employees
47
Market Cap
61.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 67.55B | 5.10B | 8.17% |
| Dec 31, 2024 | 62.45B | 2.44B | 4.06% |
| Dec 31, 2023 | 60.02B | -15.62B | -20.65% |
| Dec 31, 2022 | 75.64B | 8.97B | 13.45% |
| Dec 31, 2021 | 66.67B | 19.17B | 40.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dongwoo Farm To Table Co ., | 325.46B |
| IGLOO | 143.26B |
| DENTIS CO.,Ltd | 114.25B |
| Kocom | 104.02B |
| JPI Healthcare | 96.93B |
| Dongil Metal | 91.71B |
| Kyung Nam Pharm | 56.18B |
| DYD Co.,LTD. | 44.90B |